Amount of qualified sufferers: CDEC talked about the uncertainty in the amount of individuals with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who are classified as owning delicate or reasonable illness may have a intense bleeding https://anciusz467tvv0.wiki-jp.com/user